SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-19-019968
Filing Date
2019-11-07
Accepted
2019-11-07 06:31:44
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 806155
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 23430
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 13746
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 13799
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 5700
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 5708
  Complete submission text file 0001140361-19-019968.txt   4367803

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pdsb-20190930.xml EX-101.INS 740275
8 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20190930.xsd EX-101.SCH 38593
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20190930_cal.xml EX-101.CAL 39605
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20190930_def.xml EX-101.DEF 160730
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20190930_lab.xml EX-101.LAB 589029
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20190930_pre.xml EX-101.PRE 313900
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 191198015
SIC: 2834 Pharmaceutical Preparations